|
Dr. Ralph Garippa
Head of Cell-Based High Throughput Screening (HTS) and Microscopic Imaging-based High Content Screening
Roche Discovery Technologies
Dr. Garippa works at a pharmaceutical research center, where he oversees a screening program designed to detect potential new cancer drugs. In the interview he discusses the opportunites and challenges presented by this method of detecting possible cancer treatments.
|